Influenza Vaccines Market Size (2022-2030) Share, Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

| Source: Growth Plus Reports Growth Plus Reports

Pune, Sept. 16, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by growth plus reports, the global influenza vaccines market is expected to clock US$ 6.9 billion by 2030 and to grow at a CAGR of 7.5% during the forecast period. Owing to the development of new flu vaccines and government initiatives this exclusive information is published by Growth Plus Reports in its report titled “Influenza Vaccines Market – Global Outlook & Forecast 2022-2030”

Growth Drivers

Governments of various economies have developed a number of initiatives in response to the rising influenza prevalence in the world. An increase in government spending to promote influenza vaccination will boost the market for influenza vaccines. The governing bodies of various governments and nations support the promotion of vaccination through a number of initiatives and programs. The development of novel, efficient vaccines and rising leading companies' investments in R&D are also contributing to the global influenza vaccine market.

The global liver cancer therapeutics market has been analyzed from three perspectives: therapy type, end user, and region.

Download PDF Brochure of Influenza Vaccines Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/influenza-vaccines-market/7815

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global influenza vaccine market are:

  • Pfizer Inc
  • GlaxoSmithKline plc
  • Merck & Co., Inc
  • Novartis AG
  • F. Hoffman-La Roche Ltd
  • AstraZeneca plc
  • Sinovac Biotech Ltd
  • CSL Limited
  • Abbott Laboratories
  • BioDiem

Excerpts from ‘By Vaccine Type Segmentation’

On the basis of vaccine type, the global influenza vaccine market has been subdivided into two distinct types, namely:

  • Live Attenuated
  • Inactivated

The inactivated vaccine segment dominated the global influenza vaccine market. This is attributed to the increased focus of key players to develop this vaccine in developed and developing countries. And also, it is standardized according to specific strain of the influenza virus. On the other hand, the live attenuated vaccine segment would experience slow growth, since it is contraindicated in numerous patient categories and its manufacturing process is very complicated.

Get customized report as per your requirements: https://growthplusreports.com/inquiry/customization/influenza-vaccines-market/7815

Excerpts from ‘By Age Group Segmentation’

Based on age group, the global influenza vaccine market has been divided into, pediatrics and adults. The pediatric segment rules the influenza vaccine market, because of the high requirement for vaccination in infants and children to protect them against influenza virus infection. The adult segment also holds a significant share in the influenza vaccine market,because of the rise in immunization programmes initiated by government.

Excerpts from ‘By Distribution Channel Segmentation’

The global influenza vaccine market is divided into:

  • Hospital Pharmacy
  • Government Suppliers
  • Others

The market for influenza vaccines worldwide is dominated by the hospital pharmacy sector. This occurs as a result of frequent immunization campaigns held in hospitals and the large vaccine availability in these settings. In the upcoming years, the government suppliers market is anticipated to expand due to the expansion of immunization programs.

Excerpts from ‘By Region Segmentation’

Based on region, the global influenza vaccine market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Asia-Pacific is expected to prosper during the anticipated period. The market for influenza vaccines is expanding primarily due to the increasing occurrence of influenza, rising healthcare costs, and improvements in healthcare access in nations like China and India. The market for influenza vaccinations is expanding as a result of increasing government activities regarding the creation of the influenza vaccine. The demand for the influenza vaccine in the region is expected to rise over the next few years as a result of rising birth rates, an ageing population, and increased public knowledge of the vaccination in China and India.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  1. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  1. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  1. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  1. GLOBAL INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY VACCINE TYPE
    1. Live Attenuated 
    2.  Inactivated
  1. GLOBAL INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY VALENCY
    1. Quadrivalent
    2. Trivalent
  1. GLOBAL INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY AGE GROUP
    1. Pediatrics
    2. Adults
  1. GLOBAL INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL 
    1. Hospital Pharmacy
    2. Government Suppliers
    3. Others

TOC Continued….

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • Business Profile' of Key Players

Directly Purchase Premium Copy of influenza vaccines Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=QQ7ydDTWwKKwEUeThZ9ZyOX8qVVBFjL7EySv94ES&report_id=7815&license=Single

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

 

            








        

            

                

                    
Tags

                            
                                Influenza Vaccines Market
                            
                            
                                Influenza Vaccines Market Size
                            
                            
                                Influenza Vaccines trends
                            
                            
                                Influenza Vaccines outlook
                            

                



        




    

        

        
Contact Data